D. Vanrossum et al., AUTORADIOGRAPHIC DISTRIBUTION AND RECEPTOR-BINDING PROFILE OF [I-125]BOLTON HUNTER-RAT AMYLIN BINDING-SITES IN THE RAT-BRAIN, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 779-787
Amylin is a recently isolated peptide from amyloid plaques in noninsul
in-dependent diabetic patients and showed high sequence homology with
calcitonin gene-related peptide. We investigated the distribution and
the binding profile of [I-125]Bolton Hunter-rat amylin ([I-125]BH-rat
amylin) binding sites in the rat brain, as well as the affinity of rat
amylin for [I-125]hCGRP alpha binding sites in the brain, atrium (CGR
P, receptor-enriched tissue) and vas deferens (CGRP(2) receptor-enrich
ed tissue). High amounts of high affinity [I-125]BH-rat amylin binding
sites were observed in the nucleus accumbens, various hypothalamic nu
clei, amygdaloid body, dorsal raphe, tegmental and parabrachial nuclei
and the locus ceruleus. Interestingly, both rat amylin and salmon cal
citonin revealed low nanomolar affinities (2-19 nM) for [I-125]BH-rat
amylin binding sites in the Various brain areas, whereas human calcito
nin gene-related peptide-alpha (hCGRP alpha) showed lower affinities r
anging between 13 to 150 nM. Moreover, the affinity of rat amylin was
much lower than that of hCGRP alpha for [I-125]hCGRP alpha binding in
the brain, atrium and vas deferens, except for very few areas such as
the nucleus accumbens and ventral striatum. Similarly, rat amylin was
much weaker (100- to 400-fold) than hCGRP alpha to induce a biological
effect in the atrium and vas deferens. These results thus suggest the
existence of unique [I-125]BH-rat amylin binding sites in the rat bra
in as well as limited cross-reactivity between rat amylin and [I-125]h
CGRP alpha receptors present in the brain, atrium and vas deferens.